Repositorio Institucional
Repositorio Institucional
CONICET Digital
  • Inicio
  • EXPLORAR
    • AUTORES
    • DISCIPLINAS
    • COMUNIDADES
  • Estadísticas
  • Novedades
    • Noticias
    • Boletines
  • Ayuda
    • General
    • Datos de investigación
  • Acerca de
    • CONICET Digital
    • Equipo
    • Red Federal
  • Contacto
JavaScript is disabled for your browser. Some features of this site may not work without it.
  • INFORMACIÓN GENERAL
  • RESUMEN
  • ESTADISTICAS
 
Artículo

Effect of phytoderivatives on the growth of homologous beneficial vaginal lactobacilli (BVL) strains and their compatibility for the design of phytobiotics for the vaginal tract health

Marchesi, AntonellaIcon ; Silva, Jessica AlejandraIcon ; Aristimuño Ficoseco, Maria CeciliaIcon ; Wiese, Birgitt; Nader, Maria Elena FatimaIcon
Fecha de publicación: 03/2020
Editorial: World Journal of Pharmacy and Pharmaceutical Sciences
Revista: World Journal of Pharmacy and Pharmaceutical Sciences
ISSN: 2278-4357
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:
Otras Ciencias de la Salud

Resumen

Background: Lactobacilli are the predominant bacteria in the vaginal tract, and while they are present, can prevent infectious situations, being used as probiotics for the health of the tract. Phytocompounds are used historically to prevent or maintain the health of the tract, and is possible to combine both bioactives for novel vaginal formulas. The aim of this work was to study the effect of Phytocompounds (individual or combined extracts) on the growth of homologous vaginal lactic acid bacteria and their compatibility, to go further in the design of a combined pharmabiotic formula for the prevention or treatment of urogenital tract infections. Methods: the effect of phytocompounds approved by Pharcopoeias was evaluated on the growth of beneficial lactic acid bacteria previously isolated from the vaginal tract. Statistical methods, as CART, were applied to determine the stimulatory or inhibitory effect of the vegetal sources on bacterial growth by applying different methodology. Compatibility between phyto and lactobacilli was determined, and the phenolic compounds contents quantified, to define the optimal conditions for the formula design. Results: The BVL strains showing highest growth values with most of the Phytocompounds under study were L. gasseri CRL 1361, L. ga. CRL 1509 and L. ga. CRL 1263, and L. jensenii CRL 1333 and L. jen. CRL 1317, indicating the behavior is strain-dependent, and vegetable-compound-affected. The most adequate Phytocompounds were: Carica, Centella, Plantago, Uva ursi*, Zarzaparrila*, Cola de caballo, Echinaceae, Ortiga and Palo Azul. Conclusions: The BVL strains showing optimal resistance to the phytocompounds and compatibility with them were L. gasseri CRL 1320, 1307, 1509, L. salivarius CRL 1296 and L. rhamnosus CRL 1332 combined with Uva ursi*, Zarzaparrilla* and Echinaceae that will be used for the design of optimal phytobiotic formulas.
Palabras clave: BENEFICIAL VAGINAL LACTOBACILLI (BVL) , PHYTOCOMPOUNDS , PHYTOBIOTICS , DESIGN OF VAGINAL FORMULA , PHYTODERIVATIVES , PROBIOTIC PROPERTIES
Ver el registro completo
 
Archivos asociados
Tamaño: 1.473Mb
Formato: PDF
.
Solicitar
Licencia
info:eu-repo/semantics/restrictedAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/112371
URL: https://www.wjpps.com/Wjpps_controller/abstract_id/11914
Colecciones
Articulos(CERELA)
Articulos de CENTRO DE REFERENCIA PARA LACTOBACILOS (I)
Citación
Marchesi, Antonella; Silva, Jessica Alejandra; Aristimuño Ficoseco, Maria Cecilia; Wiese, Birgitt; Nader, Maria Elena Fatima; Effect of phytoderivatives on the growth of homologous beneficial vaginal lactobacilli (BVL) strains and their compatibility for the design of phytobiotics for the vaginal tract health; World Journal of Pharmacy and Pharmaceutical Sciences; World Journal of Pharmacy and Pharmaceutical Sciences; 9; 3; 3-2020; 236-261
Compartir

Enviar por e-mail
Separar cada destinatario (hasta 5) con punto y coma.
  • Facebook
  • X Conicet Digital
  • Instagram
  • YouTube
  • Sound Cloud
  • LinkedIn

Los contenidos del CONICET están licenciados bajo Creative Commons Reconocimiento 2.5 Argentina License

https://www.conicet.gov.ar/ - CONICET

Inicio

Explorar

  • Autores
  • Disciplinas
  • Comunidades

Estadísticas

Novedades

  • Noticias
  • Boletines

Ayuda

Acerca de

  • CONICET Digital
  • Equipo
  • Red Federal

Contacto

Godoy Cruz 2290 (C1425FQB) CABA – República Argentina – Tel: +5411 4899-5400 repositorio@conicet.gov.ar
TÉRMINOS Y CONDICIONES